参考文献/References:
[1]温海勋.研究血小板平均容积在疾病中的变化 [J].世界最新医学信息文摘,2017,17(1):27-28.
[2]张春英,刘兰莲.责任制整体护理模式下应用护理程序存在的问题与改进对策 [J].齐鲁护理杂志,2016,22(14):107-108.
[3]乐杰.妇产科学 [M].北京:人民卫生出版社,2008:72-74.
[4]冯燕,徐军娟.妊娠期高血压疾病患者凝血功能及血小板参数变化与疾病严重程度的相关性分析 [J].中国妇幼保健,2016,31(5):947-948.
[5]李惠娟.妊娠期高血压孕妇妊娠晚期凝血功能变化分析 [J].中外医疗,2015,34(21):8-9.
[6]史玉霞,杨一新,许倩,等.妊娠期高血压疾病患者血小板参数和凝血功能指标的变化及意义 [J].海南医学院学报,2015,21(10):1384-1386.
[7]JAGROOP I A, MIKHAILIDIS D P. Mean platelet volume is a useful parameter: a reproducible routine method using a modified Coulter Thrombocytometer [J]. Platelets, 2001, 12 (3): 171.
[8]陆奕华,吴星光,崔艳双.妊娠期高血压疾病患者凝血功能及血小板参数的变化 [J].海南医学,2014,25(12):1805-1806.
[9]刘晓洁.合体滋养细胞微绒毛膜在子痫前期发病中作用的研究 [D].重庆:第三军医大学,2014.
[10]王晓岩,王青,熊祝嘉,等.凝血指标、免疫因子和综合征病情的关系观察 [J].标记免疫分析与临床,2017,24(4):396-400.
[11]廖丹. D-二聚体、凝血指标、血小板参数检测对妊娠高血压疾病的应用价值 [J].2014,18(4):621-623.
[12]王鲁霞,路海云,温春良.责任制整体护理在优质护理病房中的实施与成效 [J].齐鲁护理杂志,2013,19(4):100-101.
[13]赵一兵.妊娠高血压孕妇血浆D-二聚体及凝血指标检测的临床意义 [J].现代医药卫生,2017,33(18):2838-2839.
[14]童蓉.西宁地区正常孕妇与妊娠期高血压疾病孕妇凝血功能的对照研究 [J].青海医药杂志,2014,44(11):18-19.
[15]KARPMAN D, LETHAGEN S, KRISTOFFERSSON A, et al. Von Willebrand factor mediates increased platelet retention in recurrent thrombotic thrombocytopenic purpura [J]. Thrombosis and Haemostasis, 1997, 78 (1): 1456-1462.
相似文献/References:
[1]黄辉秀,谭毅.妊娠期高血压疾病预测和预防的研究现状[J].中国计划生育和妇产科,2009,(05):0.
HUANG Hui-xiu,TAN Yi MCH Hospital of Fangcheng urban district,Fangchenggang city Guangxi automous region 80,et al.[J].Chinese Journal of Family Planning & Gynecotokology,2009,(10):0.
[2]张珺,仲红丽.妊娠期高血压疾病监测系统预测及早期干预520例临床分析[J].中国计划生育和妇产科,2009,(06):0.
[3]肖兵,高岩,熊庆,等.妊娠期高血压疾病的流行病学研究进展[J].中国计划生育和妇产科,2010,(01):0.
[4]何怡,赵可文,唐莉,等.卡孕栓防治妊娠期高血压疾病产后出血的疗效观察[J].中国计划生育和妇产科,2010,(02):0.
HE Yi,ZHAO Ke-wen,TANG LiMCH hospital of Dongguan city,et al.[J].Chinese Journal of Family Planning & Gynecotokology,2010,(10):0.
[5]庞春蓉,傅晓冬.肾上腺髓质素与妊娠期高血压疾病[J].中国计划生育和妇产科,2010,(02):0.
[6]陈倩,段成城,傅晓冬,等.血清T辅助细胞比率与妊娠期高血压疾病的关系和意义[J].中国计划生育和妇产科,2010,(03):0.
CHEN Qian,DUAN Cheng-cheng,FU Xiao-dong..[J].Chinese Journal of Family Planning & Gynecotokology,2010,(10):0.
[7]陈茜松,刘丽俊,季淑英,等.妊娠期高血压疾病患者血清抵抗素水平的变化及其临床意义[J].中国计划生育和妇产科,2011,(03):0.
CHEN Qian-song,LIU Li-jun,JI Shu-ying.[J].Chinese Journal of Family Planning & Gynecotokology,2011,(10):0.
[8]侯卫萍,程兰,黄立,等.血清胱抑素C在妊娠期高血压疾病中的应用[J].中国计划生育和妇产科,2011,(06):0.
HOU Wei-ping,CHENG Lan,HUANG Li.[J].Chinese Journal of Family Planning & Gynecotokology,2011,(10):0.
[9]刘圣英,杨建恩.孕期补钙预防高危孕妇妊娠期高血压疾病的临床观察[J].中国计划生育和妇产科,2012,(03):0.
LIU Sheng-ying,YANG Jian-en.[J].Chinese Journal of Family Planning & Gynecotokology,2012,(10):0.
[10]金爽,尹春艳.IGF-Ⅰ、IGF-Ⅱ、IGFBP-1与妊娠期高血压疾病的相关性研究[J].中国计划生育和妇产科,2012,(05):0.
JIN Shuang,YIN Chun-yan University of South China Teaching Hospital,the Second Peoples Hospital in Guangdong Province,et al.[J].Chinese Journal of Family Planning & Gynecotokology,2012,(10):0.
[11]李秀军,张轶岚*,叶兆兰.川芎嗪注射液联合阿司匹林对妊娠期高血压疾病患者凝血指标及母婴结局的影响[J].中国计划生育和妇产科,2018,(8):72.
LI Xiu-jun,ZHANG Yi-lan*,YE Zhao-lan.Effect of ligustrazine injection combined with aspirin on blood coagulation index and maternal and infant outcome in patients with hypertensive disorder complicating pregnancy[J].Chinese Journal of Family Planning & Gynecotokology,2018,(10):72.